Orion shows flag at Pharma West San Francisco

Orion shows flag at Pharma West San Francisco

Orion Logo

Orion Corporation

OCTOBER 30, 2015

Espoo, Finland: – Orion Corporation will fly its banner as one of Europe’s foremost research-based life sciences manufacturers at the select Outsourced Pharma West show in San Francisco in early November.

Orion will be sending a strong team to the two -day event, headed by its Director of Sales & Marketing, Jari Kaunisto, who will bring details of key products and capabilities.

Contract manufacturing

Mr. Kaunisto will also be representing Orion’s contract manufacturing arm, with details of key capabilities and product ranges. He aims to increase awareness of Orion’s advanced CMO capabilities.

“Outsourced Pharma West represents a great opportunity for us to make American partners and customers in particular more aware of just what we can bring to the table in terms of advanced manufacturing,” said Mr. Kaunisto.

The Orion show team will use Outsourced Pharma West’s extensive networking facilities to reach out to existing and potential customers and other business contacts. They are inviting any attendees interested in face-to-face meetings to contact the company email (cmo@orion.fi) in advance to set up appointments.

About Orion Corporation

Orion develops and provides pharmaceuticals and diagnostic tests to global markets. The company has been an innovative presence in wellbeing and life sciences since 1917; initially in its native country Finland and now with direct presence in 21 European countries.

Orion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. It is continuously developing new drugs and treatment methods.

Product and service offerings from Orion and its sister company Fermion involve APIs and finished dosage forms as well as a capable marketing and sales network made available for partners’ licensing opportunities. Both Orion and Fermion also offer high value pharmaceutical contract manufacturing services for global markets.

Orion is a clear market leader in its main market Finland and also markets its products in more than 100 countries worldwide. The Group’s human pharmaceuticals sales organisation covers almost all key European markets. Several collaboration partners distribute Orion products in overseas markets.

All Orion manufacturing and most of its R&D operations are in Finland, with the group headquarters in Espoo, a short distance west of Helsinki. Orion employs some 3,500 people and in 2014 reported total worldwide sales of EUR 1,015 million (2013: EUR 1,007 m.). Orion A and B shares are listed on NASDAQ OMX Helsinki.

About Outsourced Pharma West 2015

Outsourced Pharma West was inaugurated in 2014 as an intimate elite event that brings together executives who manage outsourcing partnerships in the pharmaceutical industry.

The conferences and exhibitions are staged every six months. This third event will take place over two days, opening November 3. It returns to Hyatt Regency San Francisco Airport in Burlingame, CA, venue for the inaugural event.

More than delegates, 36 panelist speakers and some 50 exhibitors and sponsors attended the previous Outsourced Pharma West event, in San Diego.

The upcoming conference will feature panel discussions covering all the hot topics in outsourcing, including pricing and budgeting, sourcing partners, implementing tech transfer strategies, project management, up scaling to GMP production, risk management, quality reporting requirements and future trends.

The event is co-produced by Life Science Leader magazine and the California Life Sciences Association (CLSA). More information at: http://outsourcedpharmaevents.com

Media Contact

Orion Corporation
Tel: +35 810 4261
Email: cmo@orion.fi


Click on Orion shows flag at Pharma West San Francisco for more information.
Click on Orion to contact the company directly.

Supplier Information
Supplier: Orion Corporation
Address: Orionintie 1A, FI-02200 Espoo
Tel: +358 10 4261
Website: www.orion.fi

Comments are closed.